YY1 downregulated by miR-7-5p via direct 3′UTR targeting reduces stemness and enhances temozolomide sensitivity in glioblastoma, positioning the miR-7-5p/YY1 axis as a key regulator of chemoresistance. Here, YY1 is linked to glioblastoma.